Birgit Zech - Concepedia

Author

Birgit Zech

ProterixBio (United States)

Also Known As

B Zech, Birgit Zech

Publications

533

Citations

H-Index

Concepts

All Affiliations

ProterixBio (United States)Lead Discovery Center (Germany)Weatherford College Bioforschung Austria Phenex Pharmaceuticals (Germany)

About

Birgit Zech is an author at ProterixBio (United States) specializing in medicine, molecular biology, and cellular biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	315
2	Natural Sciences	2	2	173
3	Biochemistry	2	2	173
4	Cell Biology	2	2	173
5	Chemical Biology	1	1	106

Birgit Zech

Publications

530

Citations

H-Index

Page 1

	Year	Citations
Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors Stephanie Blencke, Birgit Zech, Ola Engkvist, Chemistry & Biology Drug TargetSignal TransductionMedicineReceptor Tyrosine KinasePharmacology	2004	142
Proteome-wide Identification of Cellular Targets Affected by Bisindolylmaleimide-type Protein Kinase C Inhibitors Dirk Brehmer, Klaus Godl, Birgit Zech, Molecular & Cellular Proteomics Drug TargetCdk2 Crystal StructureCellular Targets AffectedMolecular BiologyChemical Biology	2004	106
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition AC Backes, Birgit Zech, Béatrice Felber, Expert Opinion on Drug Discovery	2008	105
Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition AC Backes, Birgit Zech, Béatrice Felber, Expert Opinion on Drug Discovery	2008	83
Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein Birgit Zech, Alexander Kurtenbach, Nicole Krieger, Journal of General Virology Viral ReplicationHepatitis C VirusHcv Life CycleMolecular BiologyComplex Formation	2003	67
Discovery of 2,4-1<i>H</i>-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors Johan J. N. Veerman, Yorik B. Bruseker, Eddy Damen, ACS Medicinal Chemistry Letters	2021	17
Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen Koen F. W. Hekking, Sergio Maroto, Kees van Kekem, Journal of Medicinal Chemistry	2024	10

Page 1